Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Matthew Zada"'
Echocardiographic predictors of ventricular arrhythmias in patients with non-ischemic cardiomyopathy
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 39, Iss , Pp 100962- (2022)
Objective: Ventricular arrhythmias (VA) portend a poor prognosis in non-ischemic cardiomyopathy (NICM). In this meta-analysis we evaluated if left ventricular (LV) global longitudinal strain (GLS) and LV mechanical dispersion (LVMD) are associated wi
Externí odkaz:
https://doaj.org/article/aec4b001eb974188aad9412e8bc47c0d
Autor:
Tamara Treleaven, Matthew Zada, Rajini Nagarajah, Charles G. Bailey, John E. J. Rasko, Michael B. Morris, Margot L. Day
Publikováno v:
Cells, Vol 12, Iss 1, p 18 (2022)
L-proline (Pro) has previously been shown to support normal development of mouse embryos. Recently we have shown that Pro improves subsequent embryo development when added to fertilisation medium during in vitro fertilisation of mouse oocytes. The me
Externí odkaz:
https://doaj.org/article/5d18cc2b9ed44b3ea03a67edc9551eda
Autor:
Michael B. Morris, Sukran Ozsoy, Matthew Zada, Mark Zada, Radu C. Zamfirescu, Mariana G. Todorova, Margot L. Day
Publikováno v:
Frontiers in Physiology, Vol 11 (2020)
Groups of amino acids, and some selected amino acids, added to media used for culture of pre-implantation embryos have previously been shown to improve development in various ways including survival to the blastocyst stage, increased blastocyst cell
Externí odkaz:
https://doaj.org/article/d2c24db27b4c48448e075bd557b1d841
Autor:
Matthew Zada, Queenie Lo, Siddharth J. Trivedi, Mehmet Harapoz, Anita C. Boyd, Kerry Devine, Norman Sadick, Michel C. Tchan, Liza Thomas
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 9, Iss 1, p 11 (2022)
Fabry disease (FD) is an X-linked disorder with α-galactosidase A deficiency. Males (>30 years) and females (>40 years) often present with cardiac manifestations, predominantly left ventricular hypertrophy (LVH). The aim of this study was to evaluat
Externí odkaz:
https://doaj.org/article/5bf1ef9a61cf4ef1a4c066da5cb3f531
Autor:
Paul Geenty, Shanthosh Sivapathan, Luke D Stefani, Matthew Zada, Anita Boyd, David Richards, Fiona Kwok, Liza Thomas
Publikováno v:
European Heart Journal Open. 3
Aims The prognosis of light-chain (AL) amyloidosis, a plasma cell dyscrasia, is largely determined by the presence of cardiac involvement. Conventional staging is achieved using cardiac biomarkers (high-sensitivity troponin, N-terminal pro-beta natri